Mesothelioma and Immune Profile of Pleural Effusions

Conclusions: SS1P is well tolerated with pleuritis as the DLT at the highest dose level

. Evidence of clinical activity was noted in a group of heavily pretreated patients. Phase II clinical trials of SS1P are being planned for malignant mesothelioma and other mesothelin-expressing malignancies."

Mesothelioma and Immune Profile of Pleural Effusions

By: Montwrobleski77

POST COMMENT

Chemotactic and Haptotactic Properties of Mesothelioma DNA and the Human Mesothelioma Cell Line Mesothelioma Lawsuits - Fight for What You Deserve Asbestos Carcinogenicity Is Well Established And Can Lead To Mesothelioma Asbestos Dust And Dna Damage Asbestos Exposure In The Water Supply And Excess Cancer Mortality Mesothelioma Can Be Underestimated In Death Certificates Asbestos Exposure And The Carcinogenic Threshold The Excess Risk Of Cancer After Asbestos Exposure Smoking Can Increase The Number Of Asbestos Fibers In Airways The Sumner Simpson Papers - Secret Information that the Asbestos Industry Didn't Want You to Know Common Questions People Often Have About Mesothelioma Lawsuits Why Hire An Asbestos Lawyer?